Cardiovascular Disease vs. Bioterrorism

Lecture Description

Yock focuses on cardio vascular disease, which is a very profound disease - it is the # 1 killer in the western world. About half of all Medtech companies have to deal with cardio vascular diseases, he says.

Course Index

1. The Accidental Entrepreneur
2. Biotech Bay: The Other Silicon Valley
3. Biotech: Interface Between Industry and University
4. Cardiovascular Disease vs. Bioterrorism
5. Beginning of Less Invasive Cardiac Techniques: Charles Dotter
6. History of Balloon Angioplasty Catheter: Thomas Fogarty
7. Coronary Angioplasty: Andreas Geruntzig
8. Guidewire Catheter: John Simpson
9. Mentoring Changed My Life
10. Testing Medical Devices and Overcoming FDA Hurdles
11. Restentosis and Stents: Just in Time Design
12. Using Stents as Drug Delivery System
13. Opportunity: How to Cover Economic Loss from Stent Use?
14. Medtech: What's Going on in Region and at Stanford
15. Interdisciplinary Biomed Education and Clark Center at Stanford
16. Identify the Need: Invention and Being Contrary
17. MedTech: Keep it Simple
18. Patents Dominate MedTech
19. FDA and Medicare
20. Think Big and Pay Close Attention to Market Assessment
21. Envisioning the Future in Medtech: Go Where the Puck Will Be
22. Who Does Non-surgical Procedures?
23. Medical Inventions: Physicians and Entrepreneurs in Partnership
24. How are Financials for Cardiac Surgery?
25. Cost vs. Price for Medical Stents?
26. Future of Robotics in Minimally Invasive Surgery?
27. Attributes of a Successful Entrepreneur in MedTech
28. What's the Future of Medical Diagnostics?
29. Who is Leading the Stent Market Today?
30. Startups: How to Avoid Being Squashed by Big Companies?
31. Convergence and Drug Delivery
32. Medical Devices and Nanotechnology
33. Scaling Technologies to the Developing World